2004

Aguilar, D, Solomon, SD, Kober, L, Rouleau, JL, Skali, H, McMurray, JJ, Francis, GS, Henis, M, O'Connor, CM, Diaz, R, Belenkov, YN, Varshavsky, S, Leimberger, JD, Velazquez, EJ, Califf, RM, and Pfeffer, MA (2004).
Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
.

Ahn, C and Jung, SH (2004).
Efficiency of the slope estimator in repeated measurements
.

Ahn, C, Jung, SH, and Kang, SH (2004).
Weighted random regression models and dropouts
.

Al, Kh (2004).
Angiotensin-converting enzyme inhibitors: a new therapy for atrial fibrillation?
.

Al-Khatib, SM, Shaw, LK, Lee, KL, O'Connor, C, and Califf, RM (2004).
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?
.

Alexander, JH (2004).
Clinical trials in Japan and the United States
.

Alexander, JH, Dyke, CK, Yang, H, Becker, RC, Hasselblad, V, Zillman, LA, Kleiman, NS, Hochman, JS, Berger, PB, Cohen, EA, Lincoff, AM, Saint-Jacques, H, Chetcuti, S, Burton, JR, Buergler, JM, Spence, FP, Shimoto, Y, Robertson, TL, Kunitada, S, Bovill, EG, Armstrong, PW, and Harrington, RA (2004).
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot
.

Alexander, JH, Peterson, ED, Chen, AY, Harding, TM, Adams, DB, and Kisslo, JA (2004).
Feasibility of point-of-care echocardiography by internal medicine house staff
.

Alpert, JS, Shine, KI, Adams, RJ, Antman, EM, Kavey, RE, Friedman, L, Frye, RL, Harrington, RA, Korn, D, Merz, JF, and Ofili, E (2004).
Task Force 1: The ACCF and AHA codes of conduct in human subjects research
.

An, HS, Anderson, PA, Haughton, VM, Iatridis, JC, Kang, JD, Lotz, JC, Natarajan, RN, Oegema, TR, Roughley, P, Setton, LA, Urban, JP, Videman, T, Andersson, GB, and Weinstein, JN (2004).
Introduction: disc degeneration: summary
.

Anavekar, NS, McMurray, JJ, Velazquez, EJ, Solomon, SD, Kober, L, Rouleau, JL, White, HD, Nordlander, R, Maggioni, A, Dickstein, K, Zelenkofske, S, Leimberger, JD, Califf, RM, and Pfeffer, MA (2004).
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction
.

Anderson, DL, Murdoch, DR, Sexton, DJ, Reller, LB, Stout, JE, Cabell, CH, and Corey, GR (2004).
Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study
.

Anstrom, KJ, Reed, SD, Allen, AS, Glendenning, GA, and Schulman, KA (2004).
Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia
.

Apfelbaum, JL, Gan, TJ, Zhao, S, Hanna, DB, and Chen, C (2004).
Reliability and validity of the perioperative opioid-related symptom distress scale
.

Armstrong, PW, Newby, LK, Granger, CB, Lee, KL, Simes, RJ, Van, de, White, HD, and Califf, RM (2004).
Lessons learned from a clinical trial
.

Arthur, RR, Drew, RH, and Perfect, JR (2004).
Novel modes of antifungal drug administration
.

Asher, CR, Moliterno, DJ, Bhapkar, MV, McGuire, DK, Rao, SV, Holmes, DR, Newby, LK, Bates, ER, and Topol, EJ (2004).
Association of race with complications and prognosis following acute coronary syndromes
.

Baldewicz, TT, Leserman, J, Silva, SG, Petitto, JM, Golden, RN, Perkins, DO, Barroso, J, and Evans, DL (2004).
Changes in neuropsychological functioning with progression of HIV-1 infection: results of an 8-year longitudinal investigation
.

Barbagelata, A, Califf, RM, Sgarbossa, EB, Knight, D, Mark, DB, Granger, CB, Armstrong, PW, Elizari, M, Birnbaum, Y, Grinfeld, LR, Ohman, EM, and Wagner, GS (2004).
Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: insights from GUSTO I Economics and Quality of Life substudy
.

Baughman, KL, Pepine, CJ, Abrams, J, Bashore, TM, Califf, RM, Feldman, AM, Fye, WB, Griffin, BP, Myerburg, RJ, Naccarelli, GV, and Williams, ES (2004).
Working group 1: How to increase the output of cardiologists
.

Becker, RC (2004).
Protein-binding oligonucleotides: the next frontier in antithrombotic therapy
.

Becker, RC (2004).
Factor Xa-protease activated receptor interface: a paradigm for combination pharmacotherapy
.

Becker, RC (2004).
Optimizing heparin compounds: a working construct for future antithrombotic drug development
.

Becker, RC, Alexander, J, Dyke, CK, and Harrington, RA (2004).
Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease
.

Becker, RC, Alexander, J, Li, YF, Bovill, E, Spencer, FA, Robertson, TL, Kunitada, S, Dyke, CK, and Harrington, RA (2004).
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist
.